Using D-serine to improve auditory learning in people with schizophrenia

D-serine augmentation of neuroplasticity-based auditory learning in schizophrenia

NIH-funded research New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC · NIH-10489322

This study is looking at whether D-serine can help improve how people with schizophrenia process sounds and boost their memory and thinking skills through special training exercises.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionNew York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, INC NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-10489322 on NIH RePORTER

What this research studies

This research investigates how D-serine, a compound that enhances neuroplasticity, can improve auditory processing in individuals with schizophrenia. The study focuses on training exercises that challenge early auditory information processing, aiming to boost cognitive functions like verbal memory and executive functioning. Participants will receive D-serine in varying doses alongside a neuroplasticity-based auditory remediation program to assess its effectiveness in enhancing learning and cognitive performance. The approach is designed to address a critical need for better treatment options in schizophrenia.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with schizophrenia who experience difficulties with auditory processing and cognitive functions.

Not a fit: Patients who do not have schizophrenia or those with other unrelated mental health conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved cognitive functioning and daily living skills for individuals with schizophrenia.

How similar studies have performed: Previous research has shown that NMDAR glycine site agonists like D-serine can enhance neuroplasticity, indicating potential for success in this novel approach.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Mental disordersMental health disordersPsychiatric DiseasePsychiatric Disorderpsychological disorder
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.